Founded in 2009, 2B BlackBio offers solutions through its patented ‘site-directed microsequencing’ technology in the fields of preventative, personalized medicine, medical diagnostics and pharmacogenetics. Its development work is focused on metabolism, oncology, the cardiovascular system and microbiology.
Using ‘site-directed microsequencing’ technology it’s possible to manufacture fast diagnostic tests that identify the presence of harmful fungi and bacteria within a matter of hours. In this manner it’s possible to make timely diagnoses and decide on an appropriate treatment program that facilitates a patient’s recovery.
One example of this is identifying pathogens related to sepsis, which is caused by microorganisms that lead to systematic inflammation. Treatment depends on determining what kinds of organisms are causing the disease.
The company 2B BlackBio also has a division called Genotest, focused on applied genetics. It offers services for genetic analysis in the fields of nutrition, sports, metabolic diseases, cardiovascular diseases and the personalized treatment of cancer.
Biotools B & M Labs is a leading biotechnology company in the areas of reagents, applications and molecular biology technologies in
The firm stands out for its patented diagnostic kits using nucleic acid amplification and the stabilization of reactions in complex mixtures (gelification), which consists of a process whereby the components of enzyme reactions are stabilized at room temperature by adding stabilizing agents.
These diagnostic kits help to reduce costs and increase efficacy for healthcare providers, as well as saving time and reducing the need for manipulating samples which can lead to cross contamination. Further, they allow carrying out amplification reactions in places which do not satisfy the normal requirements for the practice of molecular diagnostics.
Founded in 2009, 2B BlackBio offers solutions through its patented ‘site-directed microsequencing’ technology in the fields of preventative, personalized medicine, medical diagnostics and pharmacogenetics. Its development work is focused on metabolism, oncology, the cardiovascular system and microbiology.
Using ‘site-directed microsequencing’ technology it’s possible to manufacture fast diagnostic tests that identify the presence of harmful fungi and bacteria within a matter of hours. In this manner it’s possible to make timely diagnoses and decide on an appropriate treatment program that facilitates a patient’s recovery.
One example of this is identifying pathogens related to sepsis, which is caused by microorganisms that lead to systematic inflammation. Treatment depends on determining what kinds of organisms are causing the disease.
The company 2B BlackBio also has a division called Genotest, focused on applied genetics. It offers services for genetic analysis in the fields of nutrition, sports, metabolic diseases, cardiovascular diseases and the personalized treatment of cancer.
Biotools B & M Labs is a leading biotechnology company in the areas of reagents, applications and molecular biology technologies in
The firm stands out for its patented diagnostic kits using nucleic acid amplification and the stabilization of reactions in complex mixtures (gelification), which consists of a process whereby the components of enzyme reactions are stabilized at room temperature by adding stabilizing agents.
These diagnostic kits help to reduce costs and increase efficacy for healthcare providers, as well as saving time and reducing the need for manipulating samples which can lead to cross contamination. Further, they allow carrying out amplification reactions in places which do not satisfy the normal requirements for the practice of molecular diagnostics.
Founded in 2009, 2B BlackBio offers solutions through its patented ‘site-directed microsequencing’ technology in the fields of preventative, personalized medicine, medical diagnostics and pharmacogenetics. Its development work is focused on metabolism, oncology, the cardiovascular system and microbiology.
Using ‘site-directed microsequencing’ technology it’s possible to manufacture fast diagnostic tests that identify the presence of harmful fungi and bacteria within a matter of hours. In this manner it’s possible to make timely diagnoses and decide on an appropriate treatment program that facilitates a patient’s recovery.
One example of this is identifying pathogens related to sepsis, which is caused by microorganisms that lead to systematic inflammation. Treatment depends on determining what kinds of organisms are causing the disease.
The company 2B BlackBio also has a division called Genotest, focused on applied genetics. It offers services for genetic analysis in the fields of nutrition, sports, metabolic diseases, cardiovascular diseases and the personalized treatment of cancer.
Biotools B & M Labs is a leading biotechnology company in the areas of reagents, applications and molecular biology technologies in
The firm stands out for its patented diagnostic kits using nucleic acid amplification and the stabilization of reactions in complex mixtures (gelification), which consists of a process whereby the components of enzyme reactions are stabilized at room temperature by adding stabilizing agents.
These diagnostic kits help to reduce costs and increase efficacy for healthcare providers, as well as saving time and reducing the need for manipulating samples which can lead to cross contamination. Further, they allow carrying out amplification reactions in places which do not satisfy the normal requirements for the practice of molecular diagnostics.
